BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 6572032)

  • 1. Properdin factor B (Bf) and glyoxalase in Graves' disease.
    Allannic H; Fauchet R; Lorcy Y; Phengsavath H; Gueguen M; Knoi TD; Genetet B; Le Gall JY
    Acta Endocrinol (Copenh); 1983 Jan; 102(1):57-61. PubMed ID: 6572032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Properdin factor Bf polymorphism and glyoxase I allotypes in Graves' disease.
    Wenzel KW; Wenzel BE; Weise W
    Tissue Antigens; 1981 Feb; 17(2):247-8. PubMed ID: 6908967
    [No Abstract]   [Full Text] [Related]  

  • 3. Factor B (Bf) and glyoxalase genes in insulin-dependent diabetes mellitus.
    Allannic H; Fauchet R; Gueguen M; Pheng Savath H; Dinh Knoi T; Genetet B
    Diabete Metab; 1985 Feb; 11(1):22-6. PubMed ID: 3856541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA antigens associated with properdin factor B allotype BfF1.
    Dyer PA; Klouda PT; Harris R
    Tissue Antigens; 1981; 17(4):362-7. PubMed ID: 6949335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic susceptibility to diabetes mellitus: the distribution of properdin factor B (Bf) and glyoxalase (GLO) phenotypes.
    Kirk RL; Theophilus J; Whitehouse S; Court J; Zimmet P
    Diabetes; 1979 Oct; 28(10):949-51. PubMed ID: 478186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA-A, B, C, DR antigens, Bf, C4 and glyoxalase I (GLO) polymorphisms in French Basques with insulin-dependent diabetes mellitus (IDDM).
    Cambon-de Mouzon A; Ohayon E; Hauptmann G; Sevin A; Abbal M; Sommer E; Vergnes H; Ducos J
    Tissue Antigens; 1982 May; 19(5):366-79. PubMed ID: 6955994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Class III alleles and high-risk MHC haplotypes in type I diabetes mellitus, Graves' disease and Hashimoto's thyroiditis.
    Skanes VM; Barnard J; Farid N; Marshall WH; Murphy L; Rideout D; Taylor R; Xidos G; Larsen B
    Mol Biol Med; 1986 Apr; 3(2):143-57. PubMed ID: 3461234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphism of BF, C2, and GLO in Japanese patients with insulin-dependent diabetes mellitus: confirmation of an increase of BF*FT.
    Tokunaga K; Omoto K; Juji T; Itoh T
    Hum Genet; 1982; 62(1):86-8. PubMed ID: 6924917
    [No Abstract]   [Full Text] [Related]  

  • 9. HLA, complement C2, C4, properdin factor B and glyoxalase types in South Indian diabetics.
    Kirk RL; Ranford PR; Serjeantson SW; Thompson AR; Munirathnam Chetty SM; John L; Mohan V; Ramachandran A; Snehalatha C; Viswanathan M
    Diabetes Res Clin Pract; 1985 Mar; 1(1):41-7. PubMed ID: 3879724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human MHC class III (Bf, C2, C4) genes and GLO: their association with other HLA antigens and extended haplotypes in the Spanish population.
    Regueiro JR; Arnaiz-Villena A
    Tissue Antigens; 1988 Jan; 31(1):14-25. PubMed ID: 3341017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Genetic factors Bf and glyoxalase in Basedow's disease].
    Allannic H; Fauchet R; Lorcy Y; Phengsavath H; Guéguen M; Dinh KT; Le Gall JY; Genétet B
    Rev Med Interne; 1982 Jun; 3(2):129-32. PubMed ID: 6924395
    [No Abstract]   [Full Text] [Related]  

  • 12. HLA-A,B,C, and DR antigens, GLO I and Bf marker profiles in 75 Cape coloured patients with systemic lupus erythematosus (SLE).
    Klemp P; du Toit ED; Issacs S; Mody GM; Oudshoorn M
    Tissue Antigens; 1988 Jul; 32(1):12-6. PubMed ID: 3187991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Red cell glyoxalase I polymorphism in Alsace, France: linkage of GLO with Bf.
    North ML; Amann I; Tongio MM; Hauptmann G; Klein J; Mayer S
    Hum Hered; 1981; 31(1):39-41. PubMed ID: 6910464
    [No Abstract]   [Full Text] [Related]  

  • 14. Mapping of the linkage group GLO--Bf--HLA-B,C,A--PGM3. 1. Recombination frequencies.
    Kömpf J; Bissbort S; Göhler F; Schunter F; Wernet P
    Hum Genet; 1978 Nov; 44(3):313-9. PubMed ID: 730169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mapping of the linkage group GLO--Bf--HLA-B,C,A--PGM3. 2. Segregation analysis.
    Schunter F; Wernet P; Kömpf J; Bissbort S; Göhler F
    Hum Genet; 1978 Nov; 44(3):321-31. PubMed ID: 730170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution of properdin factor B and glyoxalase I (further genetic markers) in Northern Ireland.
    Hamilton P; Middleton D
    Ulster Med J; 1988 Apr; 57(1):41-4. PubMed ID: 3166548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of glyoxalase I allotypes with Graves' disease and diabetes mellitus.
    Moens H; Payne R; Carter ND; Farid NR
    Hum Hered; 1980; 30(1):62-4. PubMed ID: 6892568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An unusual "morphologic" variant of BF S.
    Raum D; Surgenor T; Awdeh Z; Marcus D; Blumenthal M; Yunis EJ; Alper CA
    Am J Hum Genet; 1984 Mar; 36(2):346-51. PubMed ID: 6585138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Properdin factor B(Bf) allele BfF1 specifies an HLA-B18 diabetogenic haplotype.
    Dornan J; Allan P; Noel EP; Larsen B; Farid NR
    Diabetes; 1980 Jun; 29(6):423-7. PubMed ID: 6929767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Properdin factor B polymorphism in four Sardinian villages.
    Borelli I; Olivetti E; Cappello N; Rendine S; Curtoni ES
    Hum Hered; 1987; 37(4):217-21. PubMed ID: 3653902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.